(1 - 13 from 15
)
History of Changes for Study: NCT Clinical Trialsclinicaltrials.gov › history › NCT
clinicaltrials.gov
Investigator: Daniel Furst. Official Title: M.D., Carl M Pearson Professor of Rheumatology. Affiliation: University of California, Los Angeles.
IL-17 inhibitors offer promising 'effective' treatment for ankylosing ...www.healio.com › news › rheumatology › il17-inhibitors-offer-promising-...
www.healio.com
Sep 11, · Daniel Furst, MD. Daniel E. Furst. “That is a difference,” Furst said. “So, it looks very specifically that this anti-IL-17A was effective.”.
sorted by relevance / date